Projects funded by the NCN

Possible significance of blood platelet COX-1 glycation and ubiquitination in understaniding of the molecular background...

Call: PRELUDIUM 9 , Panel: NZ5

Principal investigator: Hassan Muhieddine Kassassir

Uniwersytet Medyczny w Łodzi

Genetic background of chromothripsis, its role in clonal evolution and response to therapy in childhood acute lymphoblas...

Call: OPUS 27 , Panel: NZ5

Principal investigator: dr hab. Agata Karolina Pastorczak

Uniwersytet Medyczny w Łodzi

In search of the causes of type 1 diabetes in children with coexisting neurodevelopmental and neurological disorders - g...

Call: PRELUDIUM 23 , Panel: NZ5

Principal investigator: Hanna Maria Kuśmierczyk-Kozieł

Uniwersytet Medyczny w Łodzi

Environmental modulation of CDK4/6 inhibitor efficacy: Impact of mycotoxin alternariol exposure on anti-cancer therapies

Call: SONATA 20 , Panel: NZ5

Principal investigator: dr Anna Dominika Walczak-Szeffer

Uniwersytet Medyczny w Łodzi

Small-molecule inhibitors of protein aggregation and ER stress as a novel strategy against neurodegeneration in the cour...

Call: PRELUDIUM BIS 3 , Panel: NZ5

Principal investigator: prof. Ireneusz Jacek Majsterek

Uniwersytet Medyczny w Łodzi

Profiling of the stroma by spatial transcriptomics in aid of prognostication in FGFR2-mediated luminal breast cancer

Call: PRELUDIUM 23 , Panel: NZ5

Principal investigator: Julia Maria Sołek-Siejka

Uniwersytet Medyczny w Łodzi

The mechanism of small non-coding RNA (microRNA)-155 role in development of autoimmune demyelination.

Call: SONATA 9 , Panel: NZ6

Principal investigator: dr Maria Cichalewska-Studzińska

Uniwersytet Medyczny w Łodzi

Prioritizing diagnostics and therapeutics of human prion diseases through integrative omics

Call: WEAVE-UNISONO , Panel: NZ2

Principal investigator: prof. Beata Sikorska

Uniwersytet Medyczny w Łodzi

Insufficiency of antioxidant mechanisms and dysregulation of circulating miRNA profiles as a cause of delayed cerebral i...

Call: OPUS 27 , Panel: NZ5

Principal investigator: dr Karol Marek Wiśniewski

Uniwersytet Medyczny w Łodzi

Development of novel potential therapeutics in inflammatory bowel diseases based on nanoformulations employing senomodul...

Call: OPUS 27 , Panel: NZ7

Principal investigator: prof. Jakub Jerzy Fichna

Uniwersytet Medyczny w Łodzi

Assessment of long-term effects of semaglutide administered in repeated short cycles in obese mice

Call: OPUS 27 , Panel: NZ7

Principal investigator: dr hab. Jakub Łukasz Wojcieszak

Uniwersytet Medyczny w Łodzi

Interleukin-6 role in stabilization of atherosclerotic plaque

Call: PRELUDIUM 23 , Panel: NZ5

Principal investigator: Małgorzata Gałdyszyńska

Uniwersytet Medyczny w Łodzi

Confirmation of the role of individual genes involved in the pathogenesis of bronchial asthma with hypersensitivity to a...

Call: PRELUDIUM 1 , Panel: NZ5

Principal investigator: Dorota Wiktoria Kacprzak

Uniwersytet Medyczny w Łodzi

Expression and function of Regulator of G Protein Signaling (RGS) proteins in physiological and pathophysiological condi...

Call: SONATA 16 , Panel: NZ7

Principal investigator: dr hab. Maciej Stawnisław Sałaga

Uniwersytet Medyczny w Łodzi

Comprehensive characterization of tumor immune contexture changes induced by cytotoxic agents in non-small cell lung can...

Call: PRELUDIUM BIS 2 , Panel: NZ5

Principal investigator: prof. Wojciech Maksymilian Fendler

Uniwersytet Medyczny w Łodzi

The role of intestinal CYP2E1 in pathophysiology of the gastrointestinal tract disorders: new therapies for leaky gut sy...

Call: PRELUDIUM BIS 3 , Panel: NZ7

Principal investigator: dr hab. Maciej Stawnisław Sałaga

Uniwersytet Medyczny w Łodzi

Identifying angiogenic and metabolic biomarkers in endometriosis-associated ovarian cancer using photoacoustic imaging a...

Call: POLONEZ BIS 3 , Panel: NZ5

Principal investigator: dr Monika Anna Golińska

Uniwersytet Medyczny w Łodzi

Assessment of the potential of new histidine hybrids and simulation of their metabolism as a potential therapy for neuro...

Call: OPUS 27 , Panel: NZ7

Principal investigator: prof. Paweł Bartosz Szymański

Uniwersytet Medyczny w Łodzi

The role of EZH2 activity in the development of resistance to targeted therapy in melanoma

Call: OPUS 28 , Panel: NZ7

Principal investigator: dr Michał Jerzy Woźniak

Uniwersytet Medyczny w Łodzi